Literature DB >> 28095990

Treatment options to prevent diabetes in subjects with prediabetes: Efficacy, cost effectiveness and future outlook.

Olivia M Farr1, Christos S Mantzoros2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28095990      PMCID： PMC5871912          DOI： 10.1016/j.metabol.2016.12.017

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  46 in total

1.  Liraglutide in Weight Management.

Authors:  Xavier Pi-Sunyer
Journal:  N Engl J Med       Date:  2015-10-29       Impact factor: 91.245

2.  Thiazolidinediones attenuate lipolysis and ameliorate dexamethasone-induced insulin resistance.

Authors:  Jinhan He; Chong Xu; Jiangying Kuang; Qinhui Liu; Hongfeng Jiang; Li Mo; Bin Geng; Guoheng Xu
Journal:  Metabolism       Date:  2015-02-26       Impact factor: 8.694

3.  Should the metabolic syndrome patient with prediabetes be offered pharmacotherapy?

Authors:  Shannon D Sullivan; Robert E Ratner
Journal:  Curr Diab Rep       Date:  2011-04       Impact factor: 4.810

Review 4.  Effects of Incretin-Based Therapies and SGLT2 Inhibitors on Skeletal Health.

Authors:  Andrea Egger; Marius E Kraenzlin; Christian Meier
Journal:  Curr Osteoporos Rep       Date:  2016-12       Impact factor: 5.096

Review 5.  Acarbose Monotherapy and Type 2 Diabetes Prevention in Eastern and Western Prediabetes: An Ethnicity-specific Meta-analysis.

Authors:  Ruijie Hu; Yi Li; Qingguo Lv; Taixiang Wu; Nanwei Tong
Journal:  Clin Ther       Date:  2015-06-26       Impact factor: 3.393

6.  Metformin protects against infection-induced myocardial dysfunction.

Authors:  Theodora Tzanavari; Aimilia Varela; Stamatis Theocharis; Elpinickie Ninou; Alkistis Kapelouzou; Dennis V Cokkinos; Maria I Kontaridis; Katia P Karalis
Journal:  Metabolism       Date:  2016-07-09       Impact factor: 8.694

Review 7.  Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review.

Authors:  Stergios A Polyzos; Christos S Mantzoros
Journal:  Metabolism       Date:  2016-05-27       Impact factor: 8.694

8.  Hypoglycemic potential of nateglinide versus glyburide in patients with type 2 diabetes mellitus.

Authors:  V A Fonseca; D E Kelley; W Cefalu; M A Baron; D Purkayastha; J E Nestler; S Hsia; J E Gerich
Journal:  Metabolism       Date:  2004-10       Impact factor: 8.694

9.  Effect of Sitagliptin and Metformin on Prediabetes Progression to Type 2 Diabetes - A Randomized, Double-Blind, Double-Arm, Multicenter Clinical Trial: Protocol for the Sitagliptin and Metformin in PreDiabetes (SiMePreD) Study.

Authors:  Poobalan Naidoo; Jeffrey Wing; Virendra Rambiritch
Journal:  JMIR Res Protoc       Date:  2016-08-04

10.  Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Authors:  Steven P Marso; Gilbert H Daniels; Kirstine Brown-Frandsen; Peter Kristensen; Johannes F E Mann; Michael A Nauck; Steven E Nissen; Stuart Pocock; Neil R Poulter; Lasse S Ravn; William M Steinberg; Mette Stockner; Bernard Zinman; Richard M Bergenstal; John B Buse
Journal:  N Engl J Med       Date:  2016-06-13       Impact factor: 176.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.